Geode Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.39B | Buy |
15,437,251
+2,303,474
| +18% | +$193M | 0.07% | 231 |
|
|
2026
Q1 | $1.05B | Buy |
13,133,777
+348,875
| +3% | +$28.8M | 0.07% | 265 |
|
|
2025
Q4 | $1.08B | Sell |
12,784,902
-52,243
| -0.4% | -$4.29M | 0.07% | 240 |
|
|
2025
Q3 | $993M | Buy |
12,837,145
+114,729
| +0.9% | +$8.96M | 0.06% | 266 |
|
|
2025
Q2 | $990M | Buy |
12,722,416
+45,555
| +0.4% | +$3.4M | 0.07% | 252 |
|
|
2025
Q1 | $915M | Sell |
12,676,861
-970,480
| -7% | -$69.5M | 0.07% | 248 |
|
|
2024
Q4 | $1.01B | Buy |
13,647,341
+126,194
| +0.9% | +$8.83M | 0.08% | 219 |
|
|
2024
Q3 | $889M | Buy |
13,521,147
+284,918
| +2% | +$20.7M | 0.07% | 249 |
|
|
2024
Q2 | $1.22B | Buy |
13,236,229
+141,603
| +1% | +$12.5M | 0.11% | 162 |
|
|
2024
Q1 | $1.25B | Buy |
13,094,626
+226,482
| +2% | +$19M | 0.12% | 157 |
|
|
2023
Q4 | $978M | Buy |
12,868,144
+176,345
| +1% | +$12.3M | 0.1% | 179 |
|
|
2023
Q3 | $877M | Buy |
12,691,799
+279,749
| +2% | +$22.5M | 0.1% | 176 |
|
|
2023
Q2 | $1.17B | Buy |
12,412,050
+197,431
| +2% | +$17.2M | 0.14% | 126 |
|
|
2023
Q1 | $1.01B | Buy |
12,214,619
+78,376
| +0.6% | +$6.16M | 0.13% | 135 |
|
|
2022
Q4 | $904M | Buy |
12,136,243
+205,714
| +2% | +$15.9M | 0.13% | 155 |
|
|
2022
Q3 | $985M | Buy |
11,930,529
+199,365
| +2% | +$19.2M | 0.15% | 123 |
|
|
2022
Q2 | $1.11B | Buy |
11,731,164
+272,554
| +2% | +$28.2M | 0.16% | 111 |
|
|
2022
Q1 | $1.35B | Buy |
11,458,610
+358,768
| +3% | +$40.2M | 0.17% | 104 |
|
|
2021
Q4 | $1.43B | Buy |
11,099,842
+517,261
| +5% | +$60.3M | 0.17% | 101 |
|
|
2021
Q3 | $1.19B | Buy |
10,582,581
+358,020
| +4% | +$40.9M | 0.16% | 112 |
|
|
2021
Q2 | $1.06B | Buy |
10,224,561
+312,507
| +3% | +$29.5M | 0.15% | 121 |
|
|
2021
Q1 | $827M | Buy |
9,912,054
+122,660
| +1% | +$10.4M | 0.13% | 138 |
|
|
2020
Q4 | $891M | Sell |
9,789,394
-238,879
| -2% | -$19.8M | 0.15% | 124 |
|
|
2020
Q3 | $799M | Sell |
10,028,273
-124,541
| -1% | -$9.72M | 0.16% | 119 |
|
|
2020
Q2 | $700M | Sell |
10,152,814
-134,429
| -1% | -$9.55M | 0.15% | 133 |
|
|
2020
Q1 | $646M | Sell |
10,287,243
-249,204
| -2% | -$18M | 0.17% | 123 |
|
|
2019
Q4 | $818M | Buy |
10,536,447
+630,618
| +6% | +$49.2M | 0.17% | 113 |
|
|
2019
Q3 | $725M | Buy |
9,905,829
+1,691,031
| +21% | +$119M | 0.17% | 113 |
|
|
2019
Q2 | $505M | Sell |
8,214,798
-592,494
| -7% | -$35.8M | 0.12% | 165 |
|
|
2019
Q1 | $561M | Sell |
8,807,292
-20,190
| -0.2% | -$1.15M | 0.15% | 130 |
|
|
2018
Q4 | $450M | Buy |
8,827,482
+606,744
| +7% | +$30.7M | 0.14% | 143 |
|
|
2018
Q3 | $476M | Buy |
8,220,738
+236,784
| +3% | +$11.6M | 0.13% | 144 |
|
|
2018
Q2 | $387M | Buy |
7,983,954
+320,820
| +4% | +$15M | 0.12% | 166 |
|
|
2018
Q1 | $356M | Buy |
7,663,134
+456,507
| +6% | +$19.8M | 0.12% | 179 |
|
|
2017
Q4 | $270M | Buy |
7,206,627
+279,147
| +4% | +$10.2M | 0.09% | 223 |
|
|
2017
Q3 | $252M | Buy |
6,927,480
+183,732
| +3% | +$7.01M | 0.09% | 218 |
|
|
2017
Q2 | $265M | Sell |
6,743,748
-89,250
| -1% | -$3.26M | 0.1% | 196 |
|
|
2017
Q1 | $214M | Buy |
6,832,998
+386,760
| +6% | +$12.1M | 0.09% | 237 |
|
|
2016
Q4 | $201M | Buy |
6,446,238
+278,460
| +5% | +$9.02M | 0.09% | 218 |
|
|
2016
Q3 | $248M | Buy |
6,167,778
+312,480
| +5% | +$11.8M | 0.12% | 166 |
|
|
2016
Q2 | $194M | Buy |
5,855,298
+193,374
| +3% | +$6.62M | 0.11% | 199 |
|
|
2016
Q1 | $166K | Buy |
5,661,924
+198,426
| +4% | +$5.48M | 0.09% | 225 |
|
|
2015
Q4 | $144M | Buy |
5,463,498
+106,524
| +2% | +$2.77M | 0.08% | 250 |
|
|
2015
Q3 | $127M | Sell |
5,356,974
-322,776
| -6% | -$7.79M | 0.08% | 267 |
|
|
2015
Q2 | $135M | Buy |
5,679,750
+40,704
| +0.7% | +$919K | 0.08% | 263 |
|
|
2015
Q1 | $134M | Buy |
5,639,046
+339,282
| +6% | +$7.61M | 0.08% | 272 |
|
|
2014
Q4 | $112M | Buy |
5,299,764
+212,316
| +4% | +$4.27M | 0.07% | 303 |
|
|
2014
Q3 | $86.5M | Sell |
5,087,448
-8,658
| -0.2% | -$137K | 0.06% | 338 |
|
|
2014
Q2 | $72.9M | Buy |
5,096,106
+441,456
| +9% | +$5.98M | 0.05% | 385 |
|
|
2014
Q1 | $57.5M | Sell |
4,654,650
-57,750
| -1% | -$666K | 0.04% | 430 |
|
|
2013
Q4 | $51.6M | Sell |
4,712,400
-70,200
| -1% | -$791K | 0.04% | 448 |
|
|
2013
Q3 | $55.5M | Buy |
4,782,600
+128,550
| +3% | +$1.5M | 0.04% | 400 |
|
|
2013
Q2 | $52.1M | Buy |
+4,654,050
| New | +$55.1M | 0.05% | 387 |
|
Other funds holding EW
VCM
VPM
Geode Capital Management's EW Position: Q2 2026 in Review
Geode Capital Management increased its Edwards Lifesciences (EW) stake by 18% in Q2 2026, buying an estimated $193M and bringing the position to 15,437,251 shares worth $1.39B. The position accounts for 0.07% of the portfolio, ranked #231.
Geode Capital Management first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.43B in Q4 2021. 1,096 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Geode Capital Management held 15,437,251 shares of Edwards Lifesciences worth $1.39B as of Q2 2026.
- Geode Capital Management bought 2,303,474 Edwards Lifesciences shares in Q2 2026, an estimated $193M.
- Edwards Lifesciences made up 0.07% of Geode Capital Management's portfolio in Q2 2026, its #231 holding.
- Geode Capital Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- Geode Capital Management's Edwards Lifesciences position peaked at $1.43B in Q4 2021.
- 1,096 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.